# Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study

> **NCT05400408** · NA · UNKNOWN · sponsor: **Scentech Medical Technologies Ltd** · enrollment: 250 (estimated)

## Conditions studied

- Colorectal Cancer
- Pancreatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** VOX

## Key facts

- **NCT ID:** NCT05400408
- **Lead sponsor:** Scentech Medical Technologies Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-01
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-03-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05400408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05400408, "Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05400408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*